Showing results (4871-4880 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|December 23, 2011
Females live longer than males: role of oxidative stressJose Vina, Juan Gambini, Raul Lopez-Grueso, et al.Current Pharmaceutical Design|August 24, 2004
Pleiotropic actions of PPAR gamma activators thiazolidinediones in cardiovascular diseasesHiroyuki Takano, Hiroshi Hasegawa, Yunzeng Zou, et al.Current Pharmaceutical Design|November 30, 2007
Recent advances in biological tissue imaging with Time-of-flight Secondary Ion Mass Spectrometry: polyatomic ion sources, sample preparation, and applicationsAlain Brunelle, Olivier LaprévoteCurrent Pharmaceutical Design|October 6, 2020
Qiliqiangxin Prescription Promotes Angiogenesis of Hypoxic Primary Rat Cardiac Microvascular Endothelial Cells via Regulating miR-21 SignalingYanyan Wang, Jingjing Zhang, Mingqiang Fu, et al.Current Pharmaceutical Design|April 28, 2005
Phospholipase A2 inhibitors as potential anti-inflammatory agentsM C Meyer, P Rastogi, C S Beckett, et al.Current Pharmaceutical Design|June 18, 2026
Glycycoumarin Induces G2/M Cell Cycle Arrest and Apoptosis in Non-Small-Cell Lung Cancer Cells via Suppressing the PI3K/AKT/mTOR/HIF-1α PathwayYinglin Guo, Xinyu Wu, Pengying Liang, et al.Current Pharmaceutical Design|June 17, 2026
Curcumin in Acne Management: A Narrative Review of Mechanisms and EfficacyYijun Chen, Xin Zhang, Rong ZengCurrent Pharmaceutical Design|January 20, 2009
Targeted drugs and nanomedicine: present and futurePaul DebbageCurrent Pharmaceutical Design|February 23, 2012
Why and how do microbubbles enhance the effectiveness of diagnostic and therapeutic interventions in cerebrovascular disease?Stephen Meairs, Rolf Kern, Angelika AlonsoCurrent Pharmaceutical Design|February 22, 2008
Is there a relationship between insulin resistance and frailty syndrome?Angela Marie Abbatecola, Giuseppe PaolissoPageof 1,008